Condition
Recurrent Polymorphic Post-Transplant Lymphoproliferative Disorder clinical trials and research
As of November 12, 2026, Find a Trial lists 2 Recurrent Polymorphic Post-Transplant Lymphoproliferative Disorder clinical trials that are recruiting, in United States. By phase: Phase 2 (1), Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 1Country
All recruiting trials (2)
-
Epcoritamab and Lenalidomide for Refractory or Relapsed Immunodeficiency-Related Large B-Cell Lymphoma
This phase 2 trial checks if the combination of epcoritamab and lenalidomide can help people with immune-related large B-cell lymphoma that hasn’t responded to treatment or has come back.
-
Epcoritamab treatment for relapsed or refractory post-transplant lymphoproliferative disorders
This study is testing a new treatment called epcoritamab to see if it can help people with relapsed or stubborn post-transplant lymphoproliferative disorders feel better.
Related topics
Quick answers
How many Recurrent Polymorphic Post-Transplant Lymphoproliferative Disorder clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in United States. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 1, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.